Badih Elmunzer to Risk
This is a "connection" page, showing publications Badih Elmunzer has written about Risk.
Connection Strength
0.308
-
Should We Still Administer Prophylactic Rectal NSAIDs to?Average-Risk Patients Undergoing ERCP? Gastroenterology. 2016 09; 151(3):566-7.
Score: 0.119
-
An assessment of existing risk stratification guidelines for the evaluation of patients with suspected choledocholithiasis. Surg Endosc. 2016 10; 30(10):4613-8.
Score: 0.115
-
Real-World Practice Patterns in the Era of Rectal Indomethacin for Prophylaxis Against Post-ERCP Pancreatitis in a High-Risk Cohort. Am J Gastroenterol. 2020 06; 115(6):934-940.
Score: 0.039
-
A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients. Am J Gastroenterol. 2019 02; 114(2):339-347.
Score: 0.035